EATG » Hepatitis

Hepatitis

US: Louisiana proposes tapping a century-old patent law to cut hepatitis C drug prices

Continuing public concerns over high-priced hepatitis C drugs are taking a new twist as Louisiana’s top health official proposes using an obscure federal patent law to get the medicines at a…

ECDC Malta Conference Report Now Out

ECDC has announced on 04/05/2017 the finalisation and  and publication of the notes of the important Malta Presidency HIV Conference (Fast-tracking the end of AIDS in Europe – practical evidence-based interventions) held…

New report halves the number of people infected with hepatitis C worldwide

A new World Health Organization (WHO) report chops the estimated number of people around the world living with the liver-damaging hepatitis C virus (HCV) in half—but the drop has nothing…

Eiger announces U.S. IND filing of pegylated interferon lambda for hepatitis delta virus infection

LIMT HDV: Lambda interferon monotherapy in HDV study enrolling PALO ALTO, Calif., May 3, 2017 — Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the development and commercialization of targeted therapies for…

A transplant and a cure

Penn team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors Penn study results point to potential for hundreds more transplants each year CHICAGO, April 30, 2017 —…

Hepatitis B vaccination has dramatically reduced infection rates among children in Europe, but more is needed to achieve elimination

The introduction of the hepatitis B vaccine in 1982 led to a dramatic fall in the prevalence of hepatitis B virus (HBV) infections globally. Today, 4.5 million infections are prevented…

Epidemiological update: Hepatitis A outbreaks in the EU/EEA mostly affecting MSM

Since the last ECDC rapid risk assessment, which was published on 24 February 2017, 10 EU Member States (Austria, Belgium, Denmark, France, Germany, Italy, the Netherlands, Portugal, Sweden and the…

China FDA approves country’s first all-oral regimen for hepatitis C

China FDA approves country’s first all-oral regimen for chronic hepatitis C, Daklinza® (daclatasvir) in combination with Sunvepra® (asunaprevir) -- Daklinza and Sunvepra combination approved for genotype 1b, the most common…

US: New website launched to help prevent spread of hepatitis C

A group of researchers launched a new website that lays out a roadmap to curb the spread of hepatitis C. HepVu is the result of a public-private partnership aimed to…

Most HIV/HCV-positive individuals who use drugs willing to start HCV treatment

Nearly three-quarters of HIV/hepatitis C (HCV)-coinfected drug users in Vancouver, Canada, reported willingness to use direct-activing antivirals (DAAs) for HCV infection, a substantial improvement over the willingness of this group…